Recursion Pharmaceuticals Inc (RXRX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.77
• Market Cap: $1.97B
• EPS: $-1.84
• 52-Week High: $7.89
• 52-Week Low: $2.98

Market Sentiment

Recursion Pharmaceuticals Inc currently has a Neutral sentiment score of 0.08.

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. (RXRX) is an innovative clinical-stage biotechnology company headquartered in Salt Lake City, Utah, that is revolutionizing drug discovery by integrating advanced technologies across biology, chemistry, and data science. Utilizing a proprietary platform that fuses high-throughput automation with deep learning capabilities, Recursion endeavors to decipher intricate biological systems, aiming to identify and develop transformative therapies for a wide range of di...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Recursion Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RXRX pay dividends?

Recursion Pharmaceuticals Inc (RXRX) does not currently pay a regular dividend.

What is RXRX's market cap?

Recursion Pharmaceuticals Inc (RXRX) has a market capitalization of $1.97B with a current stock price of $3.77.